Biovica International AB Stock price

Equities

BIOVIC B

SE0008613731

Biotechnology & Medical Research

Delayed Nasdaq Stockholm 07:41:41 2024-03-28 am EDT 5-day change 1st Jan Change
2.435 SEK -1.62% Intraday chart for Biovica International AB -3.75% -5.62%
Sales 2024 * 10M 935K Sales 2025 * 116M 10.85M Capitalization 208M 19.46M
Net income 2024 * -110M -10.29M Net income 2025 * -51M -4.77M EV / Sales 2024 * 12.1 x
Net cash position 2024 * 86.7M 8.11M Net cash position 2025 * 43.01M 4.02M EV / Sales 2025 * 1.42 x
P/E ratio 2024 *
-0.19 x
P/E ratio 2025 *
-0.83 x
Employees 37
Yield 2024 *
-
Yield 2025 *
-
Free-Float 92.54%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.20%
1 week-1.98%
Current month+16.98%
1 month+12.47%
3 months-7.98%
6 months-65.79%
Current year-3.88%
More quotes
1 week
2.36
Extreme 2.355
2.78
1 month
1.85
Extreme 1.852
2.78
Current year
1.85
Extreme 1.852
3.40
1 year
1.85
Extreme 1.852
10.36
3 years
1.85
Extreme 1.852
69.00
5 years
1.85
Extreme 1.852
69.00
10 years
1.85
Extreme 1.852
69.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 09-12-31
Director of Finance/CFO 59 22-12-31
Chief Tech/Sci/R&D Officer 45 21-12-31
Members of the board TitleAgeSince
Chairman 64 19-03-19
Director/Board Member 61 19-12-31
Director/Board Member 68 15-12-31
More insiders
Date Price Change Volume
24-03-28 2.435 -1.62% 11 372
24-03-27 2.475 -1.98% 220,706
24-03-26 2.525 -0.20% 50,618
24-03-25 2.53 -0.20% 87,266
24-03-22 2.535 +0.20% 223,699

Delayed Quote Nasdaq Stockholm, March 28, 2024 at 05:14 am EDT

More quotes
Biovica International AB is a Sweden-based biotechnology company. It develops and commercializes blood-based biomarker assays for the monitoring of cancer therapies and for prediction of patient outcome. The Company has focus on breast cancer and its main product DiviTum is a blood-based test, which measures the activity of the enzyme thymidine kinase-1 (TK) in blood serum or cell cultures. The Company collaborates with numerous institutions, such as Karolinska Institutet in Sweden and Dana Farber Cancer Institute, Washington University, Baylor College of Medicine, City of Hope Research & Treatment Center in the Unites States, as well as The International Breast Cancer Study Group (IBCSG) based in Switzerland and Breast International Group in Belgium.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.475 SEK
Average target price
15 SEK
Spread / Average Target
+506.06%
Consensus
  1. Stock
  2. Equities
  3. Stock Biovica International AB - Nasdaq Stockholm